SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: A proposed standardization framework

Rudolf A. Werner, Lilja B. Solnes, Mehrbod S. Javadi, Alexander Weich, Michael A. Gorin, Kenneth J. Pienta, Takahiro Higuchi, Andreas K. Buck, Martin G. Pomper, Steven P. Rowe, Constantin Lapa

Research output: Contribution to journalArticle

Abstract

Reliable standards and criteria for somatostatin receptor (SSTR) PET are still lacking. We herein propose a structured reporting system on a 5-point scale for SSTR PET imaging, titled SSTR-RADS version 1.0, which might serve as a standardized assessment for both diagnosis and treatment planning in neuroendocrine tumors. SSTR-RADS could guide the imaging specialist in interpreting SSTR PET scans, facilitate communication with the referring clinician so that appropriate workup for equivocal findings is pursued, and serve as a reliable tool for patient selection for planned peptide receptor radionuclide therapy.

Original languageEnglish (US)
Pages (from-to)1085-1091
Number of pages7
JournalJournal of Nuclear Medicine
Volume59
Issue number7
DOIs
StatePublished - Jul 1 2018

Keywords

  • Ga-DOTATATE/-TOC
  • Neuroendocrine tumor
  • PET
  • PRRT
  • Peptide receptor radionuclide therapy
  • RADS
  • SSTR
  • Somatostatin receptor

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: A proposed standardization framework'. Together they form a unique fingerprint.

  • Cite this